| pubmed-article:15865226 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15865226 | lifeskim:mentions | umls-concept:C0042749 | lld:lifeskim |
| pubmed-article:15865226 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15865226 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15865226 | lifeskim:mentions | umls-concept:C0209738 | lld:lifeskim |
| pubmed-article:15865226 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
| pubmed-article:15865226 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:15865226 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:15865226 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15865226 | pubmed:dateCreated | 2005-5-3 | lld:pubmed |
| pubmed-article:15865226 | pubmed:abstractText | Our aim was to determine the short-term natural course of viraemia and the response to lamivudine treatment in HBeAg-negative chronic hepatitis B patients with a persistently low hepatitis B virus (HBV)-DNA level. | lld:pubmed |
| pubmed-article:15865226 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15865226 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15865226 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15865226 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15865226 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15865226 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15865226 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15865226 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15865226 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15865226 | pubmed:issn | 1359-6535 | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:IdilmanRamaza... | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:CetinkayaHüly... | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:YurdaydinCiha... | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:BozkayaHakanH | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:ErdenEsraE | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:UzunalimogluO... | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:BozdayiA... | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:CinarKubilayK | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:ErkanOzlemO | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:TüzünAliA | lld:pubmed |
| pubmed-article:15865226 | pubmed:author | pubmed-author:UzunYusufY | lld:pubmed |
| pubmed-article:15865226 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15865226 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:15865226 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15865226 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15865226 | pubmed:pagination | 319-25 | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:meshHeading | pubmed-meshheading:15865226... | lld:pubmed |
| pubmed-article:15865226 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15865226 | pubmed:articleTitle | Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia. | lld:pubmed |
| pubmed-article:15865226 | pubmed:affiliation | Department of Gastroenterology, Ankara University School of Medicine, Cebeci, Ankara-Turkey. bozkaya@medicine.ankara.edu.tr | lld:pubmed |
| pubmed-article:15865226 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15865226 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15865226 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
